First Header Logo Second Header Logo

Connection

B. Scott Segal to Immunosuppressive Agents

This is a "connection" page, showing publications B. Scott Segal has written about Immunosuppressive Agents.
Connection Strength

1.284
  1. Romeo AR, Segal BM. Treatment of neuromyelitis optica spectrum disorders. Curr Opin Rheumatol. 2019 05; 31(3):250-255.
    View in: PubMed
    Score: 0.584
  2. Segal BM, Stüve O. Primary progressive multiple sclerosis--why we are failing. Lancet. 2016 Mar 12; 387(10023):1032-1034.
    View in: PubMed
    Score: 0.466
  3. Braley TJ, Huber AK, Segal BM, Kaplish N, Saban R, Washnock-Schmid JM, Chervin RD. A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea. Sleep. 2018 08 01; 41(8).
    View in: PubMed
    Score: 0.139
  4. Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013 Jun; 26(3):307-13.
    View in: PubMed
    Score: 0.097
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.